Dluholucký S, Sirágy P, Dolezel P, Svác J, Bolgác A
Arch Dis Child. 1980 Jun;55(6):458-60. doi: 10.1136/adc.55.6.458.
An attempt was made to see if it was possible to produce antimicrobial activity in colostrum after killed Escherichia coli O111 vaccine had been given orally to expectant mothers. The colostral samples were used in vitro for the inhibition test immediately after the start of lactation. The colostrum from 7 of the 47 vaccine-treated mothers inhibited the growth of E. coli O111 compared with only one colostrum from 101 controls. No complication has occurred either in the vaccine-treated mothers or their suckling babies. The association between the presence of antimicrobial activity in the colostrum and the time of vaccine application was insignificant.
研究人员尝试探究,在给准妈妈口服灭活的大肠杆菌O111疫苗后,初乳中是否有可能产生抗菌活性。在开始泌乳后,立即采集初乳样本用于体外抑制试验。47名接种疫苗的母亲中,有7人的初乳抑制了大肠杆菌O111的生长,而101名对照组母亲中只有1人的初乳有此效果。接种疫苗的母亲及其哺乳婴儿均未出现并发症。初乳中抗菌活性的存在与疫苗接种时间之间没有显著关联。